Ebert S, Bohm V, Buttner J, Brune W, Brinkmann M, Holtappels R
PLoS Pathog. 2024; 20(8):e1012173.
PMID: 39146364
PMC: 11349235.
DOI: 10.1371/journal.ppat.1012173.
Mihalic A, Zeleznjak J, Lisnic B, Jonjic S, Juranic Lisnic V, Brizic I
Cell Mol Immunol. 2024; 21(9):959-981.
PMID: 39134803
PMC: 11364667.
DOI: 10.1038/s41423-024-01186-2.
Riedl A, Bojkova D, Tan J, Jeney A, Larsen P, Jeney C
Vaccines (Basel). 2024; 12(7).
PMID: 39066429
PMC: 11281640.
DOI: 10.3390/vaccines12070791.
Bharti R, Calabrese D
Front Transplant. 2024; 3:1388393.
PMID: 38993763
PMC: 11235306.
DOI: 10.3389/frtra.2024.1388393.
Al-Talib M, Dimonte S, Humphreys I
Cell Mol Immunol. 2024; 21(9):982-998.
PMID: 38459243
PMC: 11364786.
DOI: 10.1038/s41423-024-01140-2.
Direct antigen presentation is the canonical pathway of cytomegalovirus CD8 T-cell priming regulated by balanced immune evasion ensuring a strong antiviral response.
Buttner J, Becker S, Fink A, Brinkmann M, Holtappels R, Reddehase M
Front Immunol. 2023; 14:1272166.
PMID: 38149242
PMC: 10749961.
DOI: 10.3389/fimmu.2023.1272166.
Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.
Holtappels R, Becker S, Hamdan S, Freitag K, Podlech J, Lemmermann N
PLoS Pathog. 2023; 19(11):e1011643.
PMID: 37972198
PMC: 10688903.
DOI: 10.1371/journal.ppat.1011643.
Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.
Holtappels R, Podlech J, Freitag K, Lemmermann N, Reddehase M
Viruses. 2022; 14(6).
PMID: 35746617
PMC: 9229300.
DOI: 10.3390/v14061145.
Mast Cells Meet Cytomegalovirus: A New Example of Protective Mast Cell Involvement in an Infectious Disease.
Becker S, Reddehase M, Lemmermann N
Cells. 2022; 11(9).
PMID: 35563708
PMC: 9101682.
DOI: 10.3390/cells11091402.
Dominant Antiviral CD8 T Cell Responses Empower Prophylactic Antibody-Eliciting Vaccines Against Cytomegalovirus.
Pardieck I, van Duikeren S, Veerkamp D, Brasem D, Redeker A, van Bergen J
Front Immunol. 2022; 13:680559.
PMID: 35154089
PMC: 8828907.
DOI: 10.3389/fimmu.2022.680559.
MCMV Centrifugal Enhancement: A New Spin on an Old Topic.
Hancock T, Hetzel M, Ramirez A, Sparer T
Pathogens. 2021; 10(12).
PMID: 34959531
PMC: 8705575.
DOI: 10.3390/pathogens10121577.
The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection.
Tanimura K, Uchida A, Imafuku H, Tairaku S, Fujioka K, Morioka I
Int J Mol Sci. 2021; 22(24).
PMID: 34948284
PMC: 8704566.
DOI: 10.3390/ijms222413487.
Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely K, Podlech J, Becker S, Freitag K, Krauter S, Buscher N
Front Immunol. 2021; 12:694588.
PMID: 34489940
PMC: 8416627.
DOI: 10.3389/fimmu.2021.694588.
CARs-A New Perspective to HCMV Treatment.
Bednar C, Ensser A
Viruses. 2021; 13(8).
PMID: 34452428
PMC: 8402902.
DOI: 10.3390/v13081563.
Consequence of Histoincompatibility beyond GvH-Reaction in Cytomegalovirus Disease Associated with Allogeneic Hematopoietic Cell Transplantation: Change of Paradigm.
Reddehase M, Holtappels R, Lemmermann N
Viruses. 2021; 13(8).
PMID: 34452395
PMC: 8402734.
DOI: 10.3390/v13081530.
Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells.
Freitag K, Hamdan S, Reddehase M, Holtappels R
Pathogens. 2021; 10(8).
PMID: 34451420
PMC: 8400798.
DOI: 10.3390/pathogens10080956.
Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
Boppana S, Britt W
Methods Mol Biol. 2021; 2244:403-463.
PMID: 33555597
DOI: 10.1007/978-1-0716-1111-1_19.
gB co-immunization with GP96 enhances pulmonary-resident CD8 T cells and exerts a long-term defence against MCMV pneumonitis.
Guo B, Xu P, Chai D, Cao L, Liu L, Song T
J Cell Mol Med. 2020; 24(24):14426-14440.
PMID: 33155438
PMC: 7754068.
DOI: 10.1111/jcmm.16065.
The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.
Lim E, Jackson S, Wills M
Front Cell Infect Microbiol. 2020; 10:202.
PMID: 32509591
PMC: 7248300.
DOI: 10.3389/fcimb.2020.00202.
Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells.
Renzaho A, Podlech J, Kuhnapfel B, Blaum F, Reddehase M, Lemmermann N
Front Cell Infect Microbiol. 2020; 10:138.
PMID: 32373544
PMC: 7186302.
DOI: 10.3389/fcimb.2020.00138.